HIV drug, Cabenuva, approved by FDA; 1st injectable regimen
by Press Release from Outbreak News Today on (#5D52A)
The U.S. Food and Drug Administration today approved Cabenuva (cabotegravir and rilpivirine, injectable formulation) as a complete regimen for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults to replace a current antiretroviral regimen in those who are virologically suppressed on a stable antiretroviral regimen with no history of treatment failure and [...]
The post HIV drug, Cabenuva, approved by FDA; 1st injectable regimen appeared first on Outbreak News Today.